Brian Davis PhD University of Pittsburgh, Pittsburgh, PA, USA
Robert O Heuckeroth MD PhD The Children's Hospital of Philadelphia, Philadelphia, PA, USA
Marthe Howard PhD University of Toledo Health Sciences Campus, Toledo, OH, USA
Poi-Qing Yuan PhD UCLA and VA Greater Los Angeles, Los Angeles, CA, USA
Marcus Drake MA DM University of Bristol, UK
Janet Keast PhD University of Melbourne, Victoria, Australia
Michelle Southard-Smith PhD Vanderbilt University Medical Center, Nashville, TN, USA
Lisa Stowers PhD Scripps Research, La Jolla, CA, USA
Davide Martelli PhD University of Bologna, Bologna, Italy
Paul O’Connor PhD Augusta University, Augusta, GA, USA
Colin Reardon PhD University of California Davis, Davis, CA, USA
Rainer Straub MD University Hospital, Regensburg, Germany
Mark Chapleau PhD University of Iowa, Iowa City, IA, USA
Roy Freeman MD Harvard Medical School, Boston, MA, USA
Can Ozan Tan PhD Harvard Medical School, Boston, MA, USA
J. Andrew Taylor PhD Spaulding Rehabilitation Hospital; CV Research Lab, Cambridge MA, USA
Virginia Brooks PhD Oregon Health & Science University, Portland, OR, USA
Qi Fu MD PhD University of Texas Southwestern, Dallas, TX, USA
Frank Spradley PhD University of Mississippi Medical Center, Jackson MS, USA
Craig Steinback PhD University of Alberta, Edmonton Alberta, Canada
Susan J. Birren PhD Brandeis University, Waltham, MA, USA
Marco Mongillo PhD University of Padova, Padova, Italy
Johanna Montgomery PhD Department of Physiology, University of Auckland, Auckland, New Zealand
David J. Paterson, DPhil Oxford University, Oxford, UK
Silvia Conde PhD CEDOC, NOVA Medical School, Lisbon, Portugal
Rui B. Chang PhD Yale University School of Medicine, New Haven, CT
Robert A. Larson MS PhD University of Iowa Carver College of Medicine, Iowa City, IA, USA
Wei-Zheng Zeng PhD The Scripps Research Institute, La Jolla, CA, USA
Kevin Monahan MD, Boston University, Boston, MA, USA
Michael Gold MD Medical University of South Carolina, Charleston, SC, USA
Gaetano DeFerrari MD University of Pavia, Italy
Harikrishna Tandri MD Johns Hopkins University, MD, USA
Jason Bradfield MD University of California, Los Angeles, CA, USA
Christian Meyer MD University of Hamburg, Hamburg, Germany
Bill Farquhar PhD University of Delaware, Newark, DE, USA
Vaughan Macefield PhD University of Melbourne, Victoria, Australia
Donal O’Leary PhD Wayne State University, Detroit, MI, USA
Audrey Stone PhD University of Texas at Austin, Austin, TX, USA
Eduardo E Benarroch MD Mayo Clinic, Rochester, MN
Horacio Kaufmann MD New York University Langone Health, New York, NY, USA
Ryuji Sakakibara MD PhD Toho University Sakura Medical Center, Sakura, Japan
Tatsuya Yamamoto MD Chiba University, Chiba, Japan
Neil Herring MD DPhil University of Oxford, Oxford, UK
Dominik Linz MD PhD The University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia
Crystal Ripplinger PhD UC Davis School of Medicine, Davis, CA, USA
Stavros Stavrakis MD PhD University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
Andrew Weitz PhD
Joost Wagenaar PhD Blackfynn, Philadelphia, PA, USA
Peter Hunter PhD University of Auckland, Auckland, New Zealand
Esra Neufeld PhD IT’IS Foundation, Zurich, Switzerland
Gisele Lincevicius PhD Heart Institute, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil
John Osborn PhD University of Minnesota, Minneapolis, MN, USA
Rodrigo del Rio PhD Pontificia Universidad Católica de Chile, Santiago, Chile
Hanjun Wang MD University of Nebraska Medical Center, Omaha, NE, USA
Valentin Pavlov PhD Feinstein Institute for Medical Research, Manhasset, NY, USA
Cyndya Shibao MD Vanderbilt University, Nashville, TN, USA
Hermona Soreq PhD The Hebrew University of Jerusalem, Jerusalem, Israel
Philippe Blancou PhD Insitut de Pharmacologie Moleculaire et Cellulaire, Nice, France
Pankaj Jay Pasricha MD Johns Hopkins University, Baltimore, USA
Jacqueline Phillips DVM PhD Macquarie University, Sydney, Australia
Thomas Simon PhD Insitut de Pharmacologie Moleculaire et Cellulaire, Nice, France
Speakers to be confirmed
Kristen Smith-Edwards, PhD University of Pittsburgh, Pittsburgh, PA, USA
Hongrong Yang, PhD Northeastern University, Boston, MA, USA
Seoeun Lee, BS Columbia University, New York, NY, USA
Yehe Liu, BS/MS Case Western Reserve University, Cleveland OH, USA
Maria Jantz, BS University of Pittsburgh, Pittsburgh, PA, USA
Pradeep Rajendran, PhD UCLA, Los Angeles, CA, USA
Kristen Smith-Edwards, PhD University of Pittsburgh, Pittsburgh, PA, USA
Hongrong Yang, PhD Northeastern University, Boston, MA, USA
Seoeun Lee, BS Columbia University, New York, NY, USA
Yehe Liu, BS/MS Case Western Reserve University, Cleveland OH, USA
Maria Jantz, BS University of Pittsburgh, Pittsburgh, PA, USA
Pradeep Rajendran, PhD UCLA, Los Angeles, CA, USA
Chris Towne PhD Circuit Therapeutics, Mountain View, CA, USA
Tiago Costa PhD Columbia University, New York, NY, USA (Kenneth Shepard PhD, primary author)
Gregory Futia MS University of Colorado, Denver, CO, USA (John Caldwell PhD, primary author)
Larry Miller MD Feinstein Institute for Medical Research, Manhasset, NY, USA
Thomas Taylor-Clark PhD University of South Florida, Tampa, FL, USA
Xin Sun PhD UCSD, San Diego, CA, USA
Don Bolser PhD University of Florida, Gainesville, FL, USA
Kendall Morris PhD University of South Florida, Tampa, FL, USA
Leonardo Kapural MD PhD Carolinas Pain Institute, Winston Salem, NC, USA
Teresa Pitts PhD University of Louisville, Louisville, KY, USA
Bin Feng PhD University of Connecticut, Hartford, CT, USA
Nicole Pelot BS Duke University, Durham, NC, USA
Matthew Ward PhD Purdue University, West Lafayette, IN, USA (Terry Powley PhD, primary author)
Eric Musselman BS Duke University, Durham, NC, USA
Guillermo Monroy PhD FDA Silver Springs, MD, USA
Nicole Wiedmann PhD University of Melbourne, Parkville, VIC Australia (Peregrine Osborne PhD, primary author)
Clara Huesing BS Pennington Biomedical Research Center, Baton, Rouge, LA USA
Esther Ji MSD University of Melbourne, Parkville, VIC Australia (Janet Keast PhD, primary author)
April Herrity DC PhD University of Louisville, Louisville, KY, USA
Bhavesh Patel PhD California Medical Innovations Institute, San Diego, CA, USA
Kirill Aristovich PhD University College London, London, UK
Junqi Zhuo BS Case Western Reserve University, Cleveland, OH, USA (Michael Jenkins PhD, primary author)
Bartek Rajwa PhD Purdue University, West Lafayette, IN, USA
Martin Stebbing PhD Florey Institute, Parkville, VIC, Australia
Sophie Payne PhD Bionics Institute East Melbourne VIC Australia
Kun-Han Lu BS Purdue University, West Lafayette, IN, USA
Jiande Chen PhD Johns Hopkins University, Baltimore, MD, USA
Catia Sternini MD UCLA, Los Angeles, CA, USA
Dante Heredia BS University of Nevada, Reno, NV, USA
Joel Bornstein PhD University of Melbourne, Parkville, VIC Australia
John Tompkins PhD UCLA, Los Angeles, CA, USA
Mark Doyle PhD OHSU School of Medicine, Portland, OR, USA (Michael Andresen PhD, primary author)
Alison Moss BS Thomas Jefferson University, Philadelphia, PA, USA (Rajanikanth Vadigepalli PhD, primary author
Guy Salama PhD University of Pittsburgh, Pittsburgh, PA, USA
Arjun Fontaine PhD U Colorado Denver, Denver, CO, USA
Sarah Stanley PhD Mount Sinai, New York, NY, USA
Joseph Canzano BS University of Florida, Gainesville, FL, USA
Dennis Bourbeau PhD Cleveland FES Center, Cleveland, OH USA (Aref Smiley PhD, primary author)
Gregory A. Coffee MS Case Western Reserve University, Cleveland, OH, USA (Stephen Lewis PhD, primary author)
Leah Reznikov PhD University of Florida, Gainesville, FL, USA
Gjinovefa Kola MD Case Western Reserve University, Cleveland, OH, USA (Stephen Lewis PhD, primary author)
Yee-Hsee Hsieh PhD Case Western Reserve University, Cleveland, OH, USA (Stephen Lewis PhD, primary author)
Simon Brookes PhD Flinders University, Adelaide, South Australia, Australia
Parvin Zarei Eskikand PhD University of Melbourne, Parkville, VIC, Australia (primary author Joel Bornstein PhD, primary author)
Joel Bornstein PhD University of Melbourne, Parkville, VIC, Australia
Kun-Han Lu BS MS Purdue University, West Lafayette, IN, USA
Dr. Davis’ graduate (SUNY Stony Brook, 1983) and postgraduate training (Stony Brook, Northwestern and University of Illinois, Chicago) focused on spinal cord anatomy and physiology with an emphasis on plasticity. In his first faculty position (University of Kentucky), his research explored how growth factors regulate development and adult function of the sensory nervous system. He is currently Professor of Neurobiology at the University of Pittsburgh. There are three main research programs ongoing in his laboratory. The first employs a genetic mouse model of human pancreatic ductal adenocarcinoma (PDAC) to study the role of the nervous system in pancreatic cancer, both with respect to pain and neurogenic inflammation, which drives cancer progression.
Robert O. Heuckeroth completed undergraduate training at the University of Maryland in College Park where he studied organic chemistry and performed research in the laboratory of Dr. Patrick Mariano. He then entered the Medical Scientist Training Program at Washington University School of Medicine in St. Louis where he obtained an M.D. and Ph.D in 1990. His thesis mentor was Dr. Jeffrey I. Gordon, a developmental biologist now well known for his studies of the gut microbiome. During his Ph.D. he pursued classical biochemistry to understand mechanisms underlying protein N-myristoylation, a recently identified protein modification. Pediatrics residency and pediatric gastroenterology fellowship at St. Louis Children’s Hospital were followed by post-doctoral training with Dr. Jeffrey Milbrandt at Washington University School of Medicine in St. Louis.
Marthe received her B.A. degree from the University of California at Berkeley with an individual major in Neuroscience. She then spent time at the University of Queensland in Australia teaching physiology in the medical school. Upon returning to the United States, Marthe completed a M.S. degree in Neuroscience and Neuropharmacology at CalState San Francisco where she also taught non-majors undergraduate Biology. She completed her Ph.D. in Physiology and Biophysics at the University of California, Irvine and then postdoctoral training in Pharmacology at the University of California, San Diego. Her first faculty position was in the Department of Anatomy and Cell Biology at Columbia University. She moved to the Medical University of Ohio where she is a Professor of Neuroscience. Marthe’s research for almost 30 years focused on the transcriptional control of autonomic neuron development. More recently, her focus has become more narrowed to investigating the neural circuitry in the mouse gastrointestinal tract.
Dr. Yuan received his PhD in neuroendocrinology from Peking University Health Science Center (PUHSC) in China. After serving as a lecturer and associate professor in the Department of Histology and Embryology at PUHSC for two years, he went to Uppsala University in Sweden as a visiting scientist in the Neurobiology Laboratory, Department of Psychiatry and subsequently moved to UCLA, where he has been since that time. Currently, Dr. Yuan is a professional researcher in the Vatche and Tamar Manoukian Division of Digestive Diseases at the David Geffen School of Medicine at UCLA. Dr. Yuan has been working in the field of brain-gut interactions with the team led by Dr. Yvette Taché, and particularly focusing on the roles of CRF and its related peptides in mediating gastrointestinal motor alterations centrally and peripherally, and on the anti-inflammatory effects of brain-vagal stimulation and ghrelin agonist HM01 on the rat postoperative ileus.
Marcus Drake is Professor of Physiological Urology at the University of Bristol, and Honorary Consultant Surgeon at the Bristol Urological Institute at Southmead Hospital, Bristol, UK. He undertook his medical training at the Universities of Cambridge and Oxford and was awarded his Doctorate Thesis by the University of Oxford. He is Chief Investigator of UK NIHR grants in Male LUTS (HTAs UPSTREAM & TRIUMPH), Nocturia (RfPB PLANET), catheter design (RfPB Flume), recurrent stress incontinence (HTA PURSUIT), and UTI diagnostics (i4i QUICK). He is co-CI of an NIH RO1 grant in Physiology (sildenafil and voiding). He was CI of the pharmaceutical trials BESIDE and NEPTUNE2. He is co-investigator for NIHR studies in male stress incontinence (HTA MASTER), urodynamics (HTAs FUTURE & PRIMUS), and preparation for surgery (HTA INSPIRE).
Janet graduated with a BSc (Hons) from the University of Adelaide and PhD from Flinders University (mentored by Prof John Furness). After postdoctoral training with Prof William (“Chet”) de Groat at the University of Pittsburgh, she held a tenured academic teaching and research position at the University of Queensland, followed by an NHMRC Senior Research Fellowship at the University of New South Wales then the University of Sydney, where she was also Director of Basic Research at the Pain Management Research Institute, Royal North Shore Hospital.
Michelle earned her Bachelor of Science from the University of Oklahoma and her PhD in Genetics and Development from the University of Texas Southwestern Medical Center at Dallas where she was recognized as the Nominata Graduate. She completed postdoctoral training with Dr. David Burke at the University of Michigan, Ann Arbor in Human Genetics then moved to an Intramural Research Training Award Fellowship at the National Human Genome Research Institute at the National Institutes of Health with Dr. William Pavan. Michelle is tenured faculty at Vanderbilt University Medical Center in the Department of Medicine, Division of Genetic Medicine where she focuses on basic research and teaching and has served as Interim Division Chief (2014-2015).
Dr. Stowers obtained her PhD at Harvard University and remained there to undertake the study of olfactory-mediated behavior with Catherine Dulac. During this time she completed experiments identifying vomeronasal organ neurons as sensors for mouse pheromones. In 2002 she began independent work at The Scripps Research Institute where she remains today. Her lab is leveraging the olfactory system to identify and study the information code that underlies emotion-linked innate behavior. She has been a Pew Scholar and a Senior Scholar in Neuroscience from the Ellison Medical Foundation.
I obtained my PhD from the Department of Physiology at Monash University in Victoria Australia in 2005 before moving to Milwaukee Wisconsin for a post-doctoral position at the Medical College of Wisconsin. In 2011, I moved to the Medical College of Georgia, where I am currently an Associate Professor in the Department of Physiology and Director of the Physiology Graduate Program. My laboratory’s primary research focus has been in the field of hypertension, renal and whole animal cardiovascular physiology. I am currently the principle investigator on an RO1 from the NIDDK investigating the role of the voltage gated proton channel Hv1 on cardiovascular and renal function in the Dahl salt sensitive rat model and a project leader on a program project grant (NHLBI) investigating the role of renal medullary congestion and vasa recta pericytes on the development of renal ischemia and hypertension.
After completing a PhD in mucosal immunology, Dr. Colin Reardon has focused his research efforts on understanding how the nervous system is an active participant in regulating immune responses. During his post-doctoral training at the University of Toronto with Dr. Tak Mak, Dr. Reardon has shown that unique acetylcholine-producing B- and T-cells serve to relay information from the nervous system. Acetylcholine released by these immune cells in the cholinergic anti-inflammatory reflex is capable of blocking aberrant immune cell activation, however, the functional circuitry remains contentious. The Reardon lab is primarily focused on understanding the neuronal pathways and mechanisms of control over the immune response in order to leverage this knowledge for the treatment of chronic immunopathologies, such as Inflammatory bowel disease, or following infection with enteric bacterial pathogens.
Rainer Straub received his M.D. degree from the University of Freiburg, Germany, in 1988. He began his training in Internal Medicine at University of Freiburg and, since 1991, in Regensburg, Germany. In the year 1994, he got a fellowship to study basic aspects of the neuro-immune synapse in the Dept. of Pharmacology at the University of Vienna, Austria. Back in Regensburg, he started a Rheumatology fellowship. In 1995, he joined the faculty at University of Regensburg as Assistant Professor of Medicine. In 1997, he received his Rheumatology board certification, and in the same year he became one of the two Heads of the Laboratories of the Dept. of Internal Medicine I at Regensburg University. Since 2001, he is full professor for Experimental Medicine at Regensburg University.
Dr. Qi Fu is Director of the Women’s Heart Health Laboratory at the Institute for Exercise and Environmental Medicine at Texas Health Presbyterian Hospital Dallas, and Associate Professor of Internal Medicine at the University of Texas Southwestern Medical Center. As a medical researcher, she practiced medicine in the Department of Neurology for 8 years and has been studying autonomic circulatory control and vascular function in a wide range of populations for over 20 years. From healthy individuals and pregnant women to patients with hypertension, orthostatic intolerance, syncope or advanced heart failure with left ventricular assist devices, she has explored the field of blood pressure regulation during various interventions in great detail. One of her research focuses is sympathetic neural control of blood pressure during pregnancy in humans.
Frank T. Spradley, PhD obtained his degree under the mentorship of Dr. Jennifer Pollock, PhD from the Vascular Biology Center, Medical College of Georgia at Augusta University in 2012. He then joined the Department of Physiology & Biophysics at the University of Mississippi Medical Center (UMMC) in Jackson for post-doctoral training in experimental models of pregnancy-induced hypertension and preeclampsia with Dr. Joey Granger, PhD. In 2016, he joined the Department of Surgery, UMMC as the director of basic science research where he is currently an Associate Professor and serves as graduate faculty in the Department of Physiology. I have expertise in developing experimental animal models to study mechanisms mediating blood pressure regulation and pregnancy-induced hypertension.
I am an Associate Professor in the Faculty of Kinesiology, Sport and Recreation at the University of Alberta and a Heart and Stroke Foundation of Canada (HSFC) National New Investigator. I completed my PhD in 2010, using the microneurography technique to study chemoreflex mediate neural activation. My current research interest is in neuro-vascular adaptation and plasticity in health and disease, focusing on two human models of applied (hypoxia/altitude) and clinical (pregnancy) adaptation of sympathetic nervous system regulation. Interestingly, both “extreme” stressors exhibit sympathetic hyperactivity in otherwise healthy individuals. My lab is exploring the underlying mechanisms and implications of this sympathetic hyperactivity. My work is supported by the Heart and Stroke Foundation of Canada, Natural Sciences and Engineering Research Council of Canada, and the Canadian Foundation of Innovation.
Mark W. Chapleau, PhD, FAHA, FAAS, FAPS is Professor of Internal Medicine (Cardiovascular Medicine) & Molecular Physiology and Biophysics at the University of Iowa Carver College of Medicine and Research Health Science Specialist at the U.S. Department of Veterans Affairs Medical Center in Iowa City, Iowa, USA. He received his PhD in Physiology from the Louisiana State University Health Sciences Center in New Orleans in 1985 and has been a faculty member at the University of Iowa since 1989. Dr. Chapleau’s research focuses on neural mechanisms in cardiovascular regulation; with emphasis on baroreceptor mechanosensory transduction, modulation of excitability of baroreceptor and sympathetic neurons, and baroreflex sensitivity in health and disease.Current projects are investigating mechanisms of dysregulation in mouse models of hypertension, metabolic syndrome, hypertrophic cardiomyopathy and muscular dystrophy.
Dr. Tan obtained his Baccalaureate (2000) and Master’s (2002) degrees in biology, with a focus on computational biology and applied mathematics. In 2004, he joined Boston University’s Department of Cognitive and Neural Systems, where he pursued his doctoral research on computational neuroscience and neurotransmitter interactions in the mid-brain. Subsequently, Dr. Tan joined Cardiovascular Research Laboratory at Spaulding Rehabilitation Hospital, first as a post-doctoral researcher (2007), and then as an Instructor (2011). Throughout his post-graduate research, Dr. Tan focused on human autonomic physiology, peripheral and cerebral neurovascular function, and on analytical and statistical approaches to human physiologic data. In 2015, Dr. Tan was appointed as an Assistant Professor at the Harvard Medical School, and as the Director of Cerebrovascular Research Laboratory at Spaulding Rehabilitation Hospital. He also holds a secondary appointment at the Department of Radiology, Massachusetts General Hospital. His current research intersects state-of-the-art analytic approaches, integrated human physiology, and clinical sciences, with a particular focus on the impact of spinal cord and brain injuries on cerebrovascular function.
Susan Birren is the Zalman Abraham Kekst Professor of Neuroscience and Professor of Biology at Brandeis University in Waltham, Massachusetts. She is a member of the Brandeis Volen Center for Complex Systems and served as Dean of the College of Arts and Sciences from 2011 until 2018. She received her Ph.D. in biological chemistry from the University of California at Los Angeles and did post-doctoral work at the California Institute of Technology. In her laboratory she studies the development of the mammalian peripheral nervous system with an interest in how developing sympathetic neurons acquire their electrical and neurotransmitter properties and how appropriate connections are made with the heart and other peripheral organs. Her work has defined the genes, cells, and signaling pathways that set sympathetic activity levels and that allow co-transmission of multiple neurotransmitters. Her work has implications for understanding how the nervous system controls cardiac function and how peripheral nervous system dysfunction can lead to cardiac pathology.
David J. Paterson is Professor of Physiology and Head of the Department of Physiology, Anatomy & Genetics at the University of Oxford, and a Fellow of Merton College, Oxford. He graduated from the Universities of Otago (NZ), Western Australia and Oxford, gaining his D.Phil from Oxford and D.Sc from the University of Western Australia. He is a group leader in the British Heart Foundation Centre of Research Excellence at Oxford and is Honorary Director of the Burdon Sanderson Cardiac Science Centre in his Department. As a cardiac neurobiologist, his research focuses on the neural control of the cardiovascular system in normal and diseased states. In 2014 he was made an Honorary Fellow of The Royal Society of New Zealand, and in 2018 was awarded the Carl Ludwig Distinguished Lectureship from the American Physiological Society. He was recently Editor-in-Chief of The Journal of Physiology, and is a Fellow of The Physiological Society, Royal Society of Medicine, Royal Society of Biology and is President-elect of The Physiological Society.
Silvia Vilares Conde is a full time Professor at NOVA Medical School (NMS) and Investigator at CEDOC (Chronic Disease Research Center) of NMS. She is Graduated in Biochemistry, magister in Physiology and in 2007 she pursued her PhD in Pharmacology from both NOVA University of Lisbon and the University of Valladolid. In 2009 she was awarded with the L’Oreal Medals Honor for Women in Science. Her research focuses on understanding the physiology of the autonomic nervous system, in particular the carotid body, and its relation with pathological states as metabolic and cardiovascular diseases. She is dedicated to the characterization of pathophysiological biosignals, disease signatures and fingerprints that will allow the identification of targets for therapy, particularly bioelectronic targets, as her group recently described that high frequency electrical stimulation of carotid sinus nerve restores insulin sensitivity and glucose homeostasis in type 2 diabetes models. Additionally, knowing that obesity precedes type 2 diabetes and other comorbidities she is now interested in developing therapeutic strategies to decrease weight gain, e.g, by promoting the browning of adipose tissue.
Rui Chang, Ph.D. is an Assistant Professor in the Department of Neuroscience and the Department of Cellular and Molecular Physiology at Yale University School of Medicine. Dr. Chang received his B.S. in Biological Sciences and Biotechnology from Tsinghua University, China (2005), and his Ph.D. in Neuroscience from the University of Southern California (2011) with Dr. Emily Liman where he studied molecular and cellular mechanisms of taste transduction. He was then trained with Dr. Stephen Liberles at Harvard Medical School to investigate how body organs communicate with the brain through the vagus nerve. The Chang lab uses state-of-the-art molecular, genetic, and imaging approaches to understand the physiological functions of diverse organ-to-brain circuits, with the goal to better understand the important body-brain interface and to develop novel neuronal-based therapeutic strategies for disease intervention.
Robert A. Larson, MS, PhD, is a Postdoctoral Research Fellow in the Department of Internal Medicine (Cardiovascular Medicine) at the University of Iowa Carver College of Medicine in Iowa City, Iowa, USA. He pursued his graduate education at Michigan Technological University earning a MS in 2012 studying the influence of sleep deprivation on neural-cardiovascular regulation in humans, and a PhD in 2016 studying central neural mechanisms of sympathoexcitation in rodent models of salt-sensitive hypertension. Current projects are investigating autonomic and cardiac dysregulation in mouse models of hypertrophic cardiomyopathy with emphasis on mechanisms modulating excitability of cardiac afferent nerves, and regulation of the neuronal norepinephrine transporter in efferent cardiac sympathetic nerves.
Dr. Zeng is a postdoctoral fellow at Scripps Research and Howard Hughes Medical Institute. His research interest is to understand how neurons and non-neuronal cells decode and process cardiovascular mechanical forces in health and disease. By taking advantage of mechanobiology, electrophysiology, mouse genetic tools, virus-guided anatomical mapping, in vivo calcium imaging, and optogenetics, his overarching goal is to provide novel insights into cardiovascular physiology and novel therapeutic approaches to treat cardiovascular diseases, such as hypertension and heart arrhythmia.
Dr. Kevin Monahan, MD is a graduate of Georgetown University and the University of Connecticut School of Medicine. He completed his post-graduate training in cardiology and clinical cardiac electrophysiology at Harvard Medical School teaching hospitals. He is currently the Director of the Electrophysiology Laboratory and Arrhythmia Service at Boston University Medical Center and Associate Professor of Medicine at Boston University School of Medicine. His clinical focus is on the mechanisms of arrhythmias, advanced ablation therapies for the treatment of atrial fibrillation and ventricular tachycardia and device therapy to treat congestive heart failure and prevent sudden death.
Harikrishna Tandri is an Associate Professor of Medicine and the director of ventricular tachycardia (VT) ablation program at the Johns Hopkins University. He completed his medical degree in India and fellowship training at Johns Hopkins. His areas of interest include catheter ablation of VT and arrhythmogenic cardiomyopathy (AC). His research focuses on the role of sympathetic nervous system in arrhythmogenesis in the AC cohort. He is currently developing novel devise based therapies for minimally invasive sympathetcomy for refractory ventricular arrhythmias. His research is funded by NHLBI SBIR grants for new technology development.
Dr. Bradfield received his medical degree from Northwestern University Feinberg School of Medicine and completed his medical residency at Cedars-Sinai Medical Center. He completed his cardiology fellowship at the UCLA/VA Greater Los Angeles/San Fernando Valley and his clinical cardiac electrophysiology fellowship training at UCLA. Dr. Bradfield is currently the Director of the Specialized Program for Ventricular Tachycardia at the UCLA Cardiac Arrhythmia Center. His research interests include utilizing neuromodulation therapies to treat life-threatening ventricular arrhythmias.
Bill Farquhar is a Professor in the Department of Kinesiology & Applied Physiology at the University of Delaware. Dr. Farquhar’s research focuses on cardiovascular health. He is currently investigating the effects of dietary salt on autonomic and vascular function, as well as the effect of dehydration on sympathetic activity. He serves as a Board member of the American College of Sports Medicine and the Federation of the American Societies for Experimental Biology. He serves on the Editorial Boards of Autonomic Neuroscience: Basic and Clinical and the Journal of Applied Physiology, and he is member of the Hypertension and Microcirculation NIH study section. Dr. Farquhar served as chair of the Department of Kinesiology & Applied Physiology from 2011 – 2017, and is currently chair of the University of Delaware Institutional Review Board.
Dr. Stone is an assistant professor at The University of Texas at Austin in the Department of Kinesiology and Health Education. Her research interests include investigating the mechanisms behind the exaggerated blood pressure response to exercise in type 1 and type 2 diabetes. She specializes in the exercise pressor reflex in health and disease. Her current project focuses on the temporal effects of inflammation on the autonomic control of circulation during exercise in type 2 diabetic rats.
Dr. Ryuji Sakakibara was born and raised in Japan. He received his medical degree from the Asahikawa Medical College in 1984. Because of interest in clinical neurology, he moved forward to Chiba University (Professor Keizo Hirayama) where he subsequently worked as an assistant Professor, and a Lecturer in the Department of Neurology. He completed his Ph.D. at the Department of Neurology, Chiba University, in 1992 (Professor Takamichi hattori). From 1997 to 1998 he was a research fellow in the National Hospital for Neurology and Neurosurgery / Institute of Neurology, Queen Square, London, supervised by Professor Clare J. Fowler (retired in 2010) in the Department of Uro-Neurology. In 2007 March, he started a new Department of Neurology in Toho University, Sakura Medical Center, Sakura, Japan as an associate Professor, and as the Professor and Chair in 2016.
Tatsuya Yamamoto, MD., PhD is a neurologist whose research interest is movement disorder and autonomic dysfunction. He received his MD and PhD from Chiba University and worked at Chiba University hospital as neurologist. He is currently working at Chiba Prefectural University of Health Sciences.
Dr. Crystal Ripplinger is an Associate Professor and Vice Chair for Research in the Department of Pharmacology at UC Davis. She received her BS degree in Electrical Engineering from North Dakota State University in Fargo, North Dakota. She subsequently earned her MS and PhD degrees in Biomedical Engineering from Washington University in St. Louis, Missouri. After spending time as a postdoctoral fellow at Harvard University and Massachusetts General Hospital, she was appointed in 2010 as an Assistant Professor in the Department of Pharmacology at UC Davis. Dr. Ripplinger's research focusses on the role of the autonomic nervous system in influencing cardiac electrophysiology and contributing to ventricular arrhythmias. Her work uses state-of-the-art optical imaging and neuro-modulatory approaches in animal models of cardiovascular disease to assess the impact of autonomic input to the heart.
Dr. Stavrakis is a clinician-scientist at the University of Oklahoma Sciences Center, where he has been a faculty member at the Department of Medicine since July 2012. He completed fellowships in Clinical Cardiac Electrophysiology and Cardiology at the University of Oklahoma Health Sciences Center, where he also completed his residency. He earned his medical degree and PhD at the University of Athens Medical School, Greece. Additionally, he earned a Master of Science degree in Clinical and Translational Sciences at the University of Oklahoma Health Sciences Center. He specializes in the management of cardiac arrhythmias, both invasively (catheter ablation and device implantation) and non-invasively (pharmacotherapy).
Gisele Lincevicius received her Ph.D in Cardiovascular Physiology and Pharmacology from Federal University of São Paulo, Brazil (2017). During her PhD training, she had worked under the supervision of Dr. Ruy Campos and also developed a collaborative project with Dr. Julian Paton at the University of Bristol, UK (2016). Her outstanding contribution to the neurophysiology of renovascular hypertension was awarded international and national prizes such as Álvaro Osório de Almeida Award (2017), Alberto Malliani Association for Ethics and Research in Medicine – Malliani Award (2015), Congress of the International Union of Physiological Sciences travel award (2013) and Brazilian Symposium on Cardiovascular Physiology honorable mention (2013). Recently she works as a post-doctoral researcher in the Heart Institute, Medical School of São Paulo University, focusing on the cardio-oncology. She also acts as a reviewer in the Journal of Cellular Physiology.
Dr. John Osborn received his Ph.D. in 1986 in Physiology from the Medical College of Wisconsin where he studied the neural-cardiovascular actions of vasopressin under the mentorship of Dr. Allen Cowley, Jr. He then went to Johns Hopkins School of Medicine for a post-doctoral fellowship in Biomedical Engineering where he studies spinal level control of the sympathetic nervous system in the laboratory of Dr. Lawrence Schramm. In 1988 Dr. Osborn took a faculty position at the University of Minnesota where he currently holds the Marvin and Hadassah Bacaner Endowed Chair in Cardiovascular Physiology.
Hanjun Wang, M.D. is an Assistant Professor in the Department of Anesthesiology and courtesy Assistant professor in the Department of Cellular and Integrative Physiology at the University of Nebraska Medical Center. Dr. Wang received his M.D. degree from Nanjing Medical University, China in the year 2003. He was trained in the field of cardiovascular reflexes and exercise physiology under the mentorships of Drs. Wei Wang and Irving H. Zucker at the University of Nebraska Medical Center. Since 2010, Dr. Wang’s laboratory is continuously funded by American Heart Association and NIH institution. He is currently Editorial Board member of two peer-reviewed international journals (AJP-heart and Frontier in Physiology).
I am Professor of Gastroenterology in the Grenoble Faculty of Medicine and Hospital in Grenoble, France. I am a member of the team “Cerebral Stimulation & Systems Neuroscience” (team leader: Olivier David) at the Grenoble Institute of Neurosciences (GIN, INSERM U1216; https://neurosciences.univ-grenoble-alpes.fr/), and I was previously the team leader of the group Stress and Neurodigestive Interactions at the GIN. I work on brain-gut interactions for more than thirty years, both at the pre-clinical and clinical level, focusing on irritable bowel syndrome and inflammatory bowel diseases with a special interest on the role of stress and the autonomic nervous system in the physiopathology of such diseases. In particular, I am working on the anti-inflammatory (anti-TNF) properties of the vagus nerve (VN) through VN stimulation (VNS).
Valentin A. Pavlov, PhD is Professor at the Feinstein Institute for Medical Research, Northwell Health and Professor at the Zucker School of Medicine at Hofstra/Northwell. A main focus of Dr Pavlov’s research for the last 15 years has been the neuro-immune dialogue and the role of brain and peripheral cholinergic signaling in the regulation of inflammation and metabolism. This research has identified new therapeutic applications of cholinergic modalities, including galantamine, a clinically-approved (for Alzheimer's disease) cholinergic drug in inflammatory and metabolic disorders. Dr Pavlov’s current NIH funded research examines brain mechanisms regulating immune and metabolic functions in preclinical sepsis with a specific emphasis on neural cholinergic signaling. This research utilizes advanced pharmacological and bioelectronic approaches. Dr Pavlov is on the editorial board of Frontiers in Immunology and Journal of Neuroinflammation and serves as Executive Editor of the journals Bioelectronic Medicine and Molecular Medicine.
Cyndya A. Shibao, M.D., MSCI is an Associate Professor in the Department of Medicine at Vanderbilt University Medical Center. Dr. Shibao completed an Internal Medicine Residency, a fellowship in Clinical Pharmacology and a Masters of Science and Clinical Investigation degree at the Vanderbilt University School of Medicine. As a faculty member of the Division of Clinical Pharmacology, Dr. Shibao has played a pivotal role in the discovery of new treatment strategies for patients with rare diseases that affect the autonomic nervous system. In addition, Dr. Shibao’s research is focused on understanding the pathophysiology of obesity-associated hypertension and insulin resistance in African American women with a specific emphasis on the role of the parasympathetic nervous system. Dr. Shibao is a Board member of the American Autonomic Society, Fellow of the American Heart Association and Fellow of the American Autonomic Society.
Hermona Soreq is the Charlotte Schlesinger Professor of Molecular Biology at the University’s Alexander Silberman Institute of Life Sciences and is a founding member of the University's Edmond and Lily Safra Center for Brain Sciences and an ex-Dean oft he University’s Faculty of Science. A leader in the field of cholinesterase activities and their functions in the CNS and periphery, Soreq pioneered the application of molecular biology and genomics to the study of cholinergic signaling. She studies the molecular regulators of acetylcholine functioning under mental and metabolic stress, ageing and neurodegenerative disease, with a recent focus on its regulation in humans and mouse models by non-coding RNAs.
Dr. Pasricha received his M.D. degree from the All-India Institute of Medical Sciences, New Delhi in 1982. Subsequently he trained in internal medicine and pulmonology at Georgetown University-DC General Hospital and Tufts-New England Medical Center, respectively. Thereafter he trained in Gastroenterology at Johns Hopkins Hospital and then stayed on faculty at Johns Hopkins University, as Director of Therapeutic Endoscopy at Johns Hopkins Hospital and Associate Director of the Marvin Schuster Center for Gastrointestinal Motility.
In 1997 Dr Pasricha assumed leadership of the GI Division at the University of Texas Medical Branch, where he was the Bassel and Frances Blanton Distinguished Professorship in Internal Medicine. In August 2007, Dr. Pasricha was appointed as Chief of Gastroenterology at Stanford University of Medicine, where he served as Professor of Medicine and of Surgery until assuming his current position back at Johns Hopkins in July 2012.
Dr. Pasricha is currently the Vice Chair of Medicine for innovation and commercialization at Johns Hopkins. He is also the Director of the Johns Hopkins Center for Neurogastroenterology as well as the newly created Food, Body and Mind Center. In addition, he holds appointments as Professor in the Department of Neurosciences in the School of Medicine and at the Johns Hopkins Carey School of Business.
At a national level, Dr. Pasricha is the chair of the NIH-funded multi-center gastroparesis consortium. In the past, he served on the National Commission on Digestive Diseases, appointed by the Congress to provide a “roadmap” for progress in gastrointestinal disorders. He is also the founding Chair of the Center for Gastrointestinal Innovation and Technology, a body created by the AGA (American Gastroenterological Association) for the promotion of technological innovation in this field. Dr. Pasricha served on the FDA GI Drug Advisory Committee for several years and continues to provide advice to the Agency on an ad hoc basis. He also is a consultant for numerous biomedical device and drug companies in gastroenterology and endoscopy.
Dr. Pasricha holds more than 50 patents issued or in process by the USPTO and has co-founded several companies within both the medtech/endoscopy and biotech GI space including Apollo Endosurgery, Enterastim, First Aid Shot Therapies, NeurogastRx, Orphomed, Glyscend, Y-Trap and others. His contributions to endoscopy include the use of botulinum toxin for GI disorders, cryotherapy, novel stents, the POEM procedure and others. He is currently working with Galvani on developing a novel neuromodulation therapy for type 2 diabetes, which has become a worldwide scourge.
These diverse activities reflect his research interests, which span endoscopic, clinical and bench research. He has been a recipient of federal funding for his research since 1995 and currently is principal investigator on several NIH grants, in addition to numerous other grants and awards. His laboratory is interested in molecular mechanisms of visceral pain and gastrointestinal motility and restoration of enteric neural function with novel strategies including neural stem cell transplants. In addition, he works on neural control of glycemic control and obesity. His clinical interests include GI motility disorders and abdominal pain as well as the development of novel endoscopic procedures and devices. He has consistently been on Castle Connelly list America’s “Top Docs” as well as “Best Doctors” in America.
Dr. Pasricha has authored nearly 300 manuscripts and book chapters including contributions to Cecil Textbook of Medicine, Yamada Textbook of Gastroenterology and Goodman and Gilman’s Pharmacological Basis of Therapeutics; he has also edited and authored a textbook on visceral pain. He has been the Associate Editor for Gastroenterology, the senior editorial advisor for Digestive Diseases and Sciences and has served as Associate Editor for the Journal of Pediatric Gastroenterology and Nutrition and Associate Editor for Gastrointestinal Endoscopy.
Jacqueline Phillips is Professor of Neurophysiology in the Department of Biomedical Science in the Faculty of Medicine and Health Science at Macquarie University. She is also the current Deputy Chair of the Macquarie University Academic Senate. Jacqueline trained as a veterinarian (University of Sydney, NSW) and gained her PhD from the Australian National University (John Curtin School of Medical Research ACT). Jacqueline’s research in autonomic and sensory neuroscience is focussed on perturbations in central and peripheral control of the cardiovascular system in renal disease and the drivers of high blood pressure and autonomic dysfunction in this condition.
Dr. Lewis’s current NIH- and GSK-funded projects have fostered a multidisciplinary research program including expertise in autonomic neurophysiology/neuropharmacology and techniques in rodents ranging from (1) in vivo and in vitro recordings of neural activity within the brainstem and vagal, sympathetic and phrenic motor nerves, (2) in vivo recording of peripheral nerve activity (e.g., aortic depressor nerve, carotid sinus nerve, cervical sympathetic chain, lumbar sympathetic chain, renal nerves), electrical stimulation, (3) in vivo recordings within ganglia (e.g., nodose, superior cervical, inferior mesenteric),
Dr. Ward received his BS in Biomedical Engineering and PhD in Neural Engineering from Purdue University, West Lafayette, IN. He is currently a Research Assistant Professor of Biomedical Engineering at Purdue University (West Lafayette, IN) and an Adjunct Assistant Professor of Clinical Medicine in the Gastrointestinal Motility and Neurogastroenterology Unit in the Division of Gastroenterology and Hepatology at the Indiana University School of Medicine (Indianapolis, IN).
Dr. Ward develops and translates technologies that enable persistent, bidirectional communication with the peripheral and central nervous system. He has over a decade of focused training and experience in bioelectronic medicine, signal processing, neurophysiology and artificial intelligence in medical devices. His technology and research into noninvasive neural interfaces are part of two ongoing clinical studies at the Indiana University School of Medicine. He has three licensed patents and is a co-founder of Drug Free Therapeutix, LLC, a bioelectronics company that is developing a line of trainable neurostimulators for chronic pain and other conditions.
Dr. Ward’s BioCom Lab develops adaptive, multi-functional brain-computer interface technology and computational model-assisted neurostimulation programming tools to seamlessly connect patients to medical devices that treat gastroparesis, depression, incontinence, pain and other conditions.